$RXMD Consolidated preliminary sales for the three months ended June 30, 2020, totaled $9.32 million, representing quarterly year-over-year growth of 33.2%
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.